https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Craniomaxillofacial (CMF)

The markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural repair and temporomandibular joint (TMJ) as well as products used in thoracic surgery for sternal closure as many manufacturers often group these products within their CMF portfolio.

Showing all 9 results

Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China

more...

Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite

In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India

more...

Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite

In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our

more...

Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite

In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across

more...

Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite

In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

Overall, the global orthopedic biomaterials device market was valued at $5.6 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Europe | 2022-2028 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

The European Orthopedic Biomaterials market report covers and includes the Bone Graft Substitutes Market, Orthopedic Growth Factor Market , Orthopedic Cell Therapy Market, Hyaluronic Acid Viscosupplementation Market, and the Orthopedic Cartilage Repair Market.

more...

Orthopedic Biomaterials Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allografts, Demineralized Bone Matrices (DBMs), Xenografts, and Synthetic Bone Graft) , Orthopedic Growth Factor, and 4 more

Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $4.7 billion. Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is primarily due to the growing elderly

more...

Craniomaxillofacial and Thoracic Surgery Devices Market Report Suite | United States | 2015-2021 | MedSuite

This report covers the markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and
neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural
repair and temporomandibular joint (TMJ). The report also includes products used in thoracic surgery for
sternal closure as many manufacturers often group these products within their CMF portfolio.

more...